Intracellular effects of NSAIDs/ASA in oxidatively stressed human lens epithelial cells in culture

Ophthalmic Research

Volumn 40, Issue 2, 2008, Pages 77-85

  Petersen, A ^a   Carlsson, T ^a   Karlsson, J O ^a   Zetterberg, M ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Acetylsalicylic acid; Lens epithelial cells; Nonsteroidal anti inflammatory drugs; Oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; DICLOFENAC; GLUTATHIONE; HYDROGEN PEROXIDE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DEPOLARIZATION; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LENS EPITHELIUM; MEMBRANE POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CELL SIZE; CELLS, CULTURED; DICLOFENAC; EPITHELIAL CELLS; FREE RADICAL SCAVENGERS; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; INDOMETHACIN; INTRACELLULAR MEMBRANES; LENS, CRYSTALLINE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OXIDANTS; OXIDATIVE STRESS; PEROXIDES; PYRAZOLES; REACTIVE OXYGEN SPECIES; SULFONAMIDES; SUPEROXIDES;

EID: 39749162923     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113885     Document Type: Article

References (40)

1. Cotlier E, Sharma YR: Aspirin and senile cataracts in rheumatoid arthritis. Lancet 1981;i:338-339.
2. Seddon JM, Christen WG, Manson JE, Buring JE, Sperduto RD, Hennekens CH: Low-dose aspirin and risks of cataract in a randomized trial of us physicians. Arch Ophthalmol 1991;109:252-255.
3. Cumming RG, Mitchell P: Medications and cataract. The blue mountains eye study. Ophthalmology 1998;105:1751-1758.
4. Klein BE, Klein R, Lee KE, Danforth LG: Drug use and five-year incidence of age-related cataracts: the beaver dam eye study. Ophthalmology 2001;108:1670-1674.
5. FitzGerald GA, Patrono C: The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345:433-442.
6. Moses VS, Bertone AL: Nonsteroidal antiinflammatory drugs. Vet Clin North Am Equine Pract 2002;18:21-37.
7. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL: Cox-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002;99:13926-13931.
8. Shaftel SS, Olschowka JA, Hurley SD, Moore AH, O'Banion MK: Cox-3: A splice variant of cyclooxygenase-1 in mouse neural tissue and cells. Brain Res Mol Brain Res 2003;119:213-215.
9. Shi X, Ding M, Dong Z, Chen F, Ye J, Wang S, Leonard SS, Castranova V, Vallyathan V: Antioxidant properties of aspirin: characterization of the ability of aspirin to inhibit silica-induced lipid peroxidation, DNA damage, NF-kappaB activation, and TNF-alpha production. Mol Cell Biochem 1999;199:93-102.
10. Fernandes E, Costa D, Toste SA, Lima JL, Reis S: In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic Biol Med 2004;37:1895-1905.
11. Costa D, Gomes A, Reis S, Lima JL, Fernandes E: Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs. Life Sci 2005;76:2841-2848.
12. Rigas B, Shiff SJ: Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction. Med Hypotheses 2000;54:210-215.
13. Paterson JR, Lawrence JR: Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer. QJM 2001;94:445-448.
14. He Z, Liao Q, Xu X, Luo C, Zhou T, Li Q, Li F: A study of the acting mechanism of aspirin for resistance to oxidative damage (in Chinese). Hua Xi Yi Ke Da Xue Xue Bao 2001;32:413-416.
15. Ding H, Han C, Zhu J, Chen CS, D'Ambrosio SM: Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9. Int J Cancer 2005;113:803-810.
16. Jendrossek V, Handrick R, Belka C: Celecoxib activates a novel mitochondrial apoptosis signaling pathway. FASEB J 2003;17:1547-1549.
17. Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL: Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 2002;62:625-631.
18. Koki AT, Masferrer JL: Celecoxib: a specific COX-2 inhibitor with anticancer properties. Cancer Control 2002;9:28-35.
19. Varma SD RR: Protection against superoxide radicals in rat lens. Ophthalmic Res 1977;9:421-431.
20. Varma SD, Kumar S, Richards RD: Light-induced damage to ocular lens cation pump: prevention by vitamin C. Proc Natl Acad Sci USA 1979;76:3504-3506.
21. Beachy NA, Morris SM, Richards RD, Varma SD: Photoperoxidation of lens lipids: inhibition by aspirin. Photochem Photobiol 1987;45:677-678.
22. Spector A, Wang GM, Wang RR, Li WC, Kleiman NJ: A brief photochemically induced oxidative insult causes irreversible lens damage and cataract. II. Mechanism of action. Exp Eye Res 1995;60:483-493.
23. Petersen A, Zetterberg M, Sjostrand J, Palsson AZ, Karlsson JO: Potential protective effects of NSAIDs/ASA in oxidatively stressed human lens epithelial cells and intact mouse lenses in culture. Ophthalmic Res 2005;37:318-327.
24. Mytilineou C, Kramer BC, Yabut JA: Glutathione depletion and oxidative stress. Parkinsonism Relat Disord 2002;8:385-387.
25. Chandra J, Samali A, Orrenius S: Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 2000;29:323-333.
26. Lee CS, Kim YJ, Ko HH, Han ES: Synergistic effects of hydrogen peroxide and ethanol on cell viability loss in pc12 cells by increase in mitochondrial permeability transition. Biochem Pharmacol 2005;70:317-325.
27. Hall AG: Review: the role of glutathione in the regulation of apoptosis. Eur J Clin Invest 1999;29:238-245.
28. Katsuki H, Okuda S: Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol 1995;46:607-636.
29. Andersson M, Honarvar A, Sjostrand J, Peterson A, Karlsson JO: Decreased caspase-3 activity in human lens epithelium from posterior subcapsular cataracts. Exp Eye Res 2003;76:175-182.
30. Keelan J, Allen NJ, Antcliffe D, Pal S, Duchen MR: Quantitative imaging of glutathione in hippocampal neurons and glia in culture using monochlorobimane. J Neurosci Res 2001;66:873-884.
31. Orhan H, Marol S, Hepsen IF, Sahin G: Effects of some probable antioxidants on selenite-induced cataract formation and oxidative stress-related parameters in rats. Toxicology 1999;139:219-232.
32. Ashton M, Hanson PJ: Disparate effects of non-steroidal anti-inflammatory drugs on apoptosis in guinea-pig gastric mucous cells: inhibition of basal apoptosis by diclofenac. Br J Pharmacol 2002;135:407-416.
33. Levine L: Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors. Prostaglandins Leukot Essent Fatty Acids 2001;65:229-232.
34. Lu X, Xie W, Reed D, Bradshaw WS, Simmons DL: Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc Natl Acad Sci USA 1995;92:7961-7965.
35. Kralinger MT, Voigt M, Kieselbach GF, Hamasaki D, Hayden BC, Parel JM: Ocular delivery of acetylsalicylic acid by repetitive coulomb-controlled iontophoresis. Ophthalmic Res 2003;35:102-110.
36. Tsuchiya T, Ayaki M, Onishi T, Kageyama T, Yaguchi S: Three-year prospective randomized study of incidence of posterior capsule opacification in eyes treated with topical diclofenac and betamethasone. Ophthalmic Res 2003;35:67-70.
37. Halliwell B, Guttridge J: Free Radicals in Biology and Medicine. Oxford University Press, New York, 1999.
38. Forman HJ, Dickinson DA: Oxidative signaling and glutathione synthesis. Biofactors 2003;17:1-12.
39. Dickinson DA, Moellering DR, Iles KE, Patel RP, Levonen AL, Wigley A, Darley-Usmar VM, Forman HJ: Cytoprotection against oxidative stress and the regulation of glutathione synthesis. Biol Chem 2003;384:527-537.
40. Garcia-Ruiz C, Colell A, Morales A, Kaplowitz N, Fernandez-Checa JC: Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol 1995;48:825-834.